Search clinical trials for: SCB01A

Total 37 results

SynCore Biotechnology Co., Ltd.

No longer available

Long-Term Compassionate Use Study for Continued Administration of SCB01A-01

Malignant Solid Tumour
SynCore Biotechnology Co., Ltd.

Completed

A Dose Escalation Study of SCB01A in Subjects With Advanced Solid Tumors Who Have Failed Standard Therapy

Solid Tumors

Taiwan
SynCore Biotechnology Co., Ltd.

Terminated

Study of SCB01A in Patient With Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma

Taiwan
Guangzhou JOYO Pharma Co., Ltd

Completed

The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Pulmonary Fibrosis | Diopathic Pulmonary Fibrosis

China
Sancilio and Company, Inc.

Withdrawn

The Efficacy of EPA+DHA (SC401B) for Lowering Triglyceride Levels (≥ 500 mg/dL)

Severe Hypertriglyceridemia
SynCore Biotechnology Co., Ltd.

Terminated

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
Samaritan Pharmaceuticals, Inc

Unknown

A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients

HIV Infections

United States
LegoChem Biosciences, Inc

Completed

IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers

Healthy

Korea, Republic of
Guangzhou JOYO Pharma Co., Ltd

Recruiting

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

China
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

Asthma

Germany
Guangzhou JOYO Pharma Co., Ltd

Completed

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Idiopathic Pulmonary Fibrosis

China
LegoChem Biosciences, Inc

Completed

A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK

Pulmonary Tuberculosis

Korea, Republic of
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Tolerability, and Pharmacokinetics of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects

Asthma

Germany
LegoChem Biosciences, Inc

Completed

Multiple Ascending Dose, Phase 1 Clinical Study of LCB01-0371

Healthy

Korea, Republic of
Samaritan Pharmaceuticals, Inc

Unknown

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

HIV Infections | Human Immunodeficiency Virus

United States
Jinling Hospital, China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Enrolling by invitation

A Study of TH-SC01 for Treating Complex Perianal Fistula in Perianal Crohn's Disease.

Crohn's Disease

China
LegoChem Biosciences, Inc

Completed

To Evaluate the Effect of Food on Pharmacokinetics(PK), Phase I Clinical Study of LCB01-0371

Healthy

Korea, Republic of
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Tolerability, and Pharmacokinetics After Multiple Doses of Orally Inhaled DNAzyme Solution for Nebulisation in Healthy Male Subjects

Asthma

Germany
Samaritan Pharmaceuticals, Inc

Completed

A Dose Response and Safety Study of Procaine HCl in HIV-Infected Patients

HIV Infections

United States
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Changhai Hospital

Not yet recruiting

A Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Crohn's Disease | Perianal Fistula
LegoChem Biosciences, Inc

Terminated

An Open-label, Single Dose, Parallel Design, Phase 1 Clinical Study of LCB01-0371

Healthy

Korea, Republic of
Mansoura University Hospital

Unknown

Drug Resistant Epilepsy: Clinical and Genetic Study

Epilepsy, Drug Resistant

Egypt
LegoChem Biosciences, Inc

Completed

A Mass Balance Study of LCB01-0371 After a Single Oral LCB01-0371 Dose With a [14C]LCB01-0371-microtrace

Healthy

Korea, Republic of
Sterna Biologicals GmbH & Co. KG

Completed

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Asthma

Germany
LegoChem Biosciences, Inc

Completed

Multiple Ascending Dose Study for LCB01-0371

Healthy

Korea, Republic of
Jinling hospital Nanjing, Jiangsu, China
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.

Recruiting

A Study of TH-SC01 in the Treatment of Radiation-induced Rectal Injury

Rectal Injury

China
LegoChem Biosciences, Inc

Recruiting

A Phase 2a Study, Effect of Vancomycin With vs Without Delpazolid (LCB01-0371) in Patients With MRSA Bacteremia

MRSA Bacteremia

Korea, Republic of
LegoChem Biosciences, Inc

Completed

Trial to Evaluate Bioequivalence of LCB01-0371 in Different Batches

Healthy

Korea, Republic of
Sterna Biologicals GmbH & Co. KG

Completed

Efficacy, Pharmacokinetics, Tolerability, Safety of SB012 Intrarectally Applied in Active Ulcerative Colitis Patients (SECURE)

Colitis, Ulcerative

Germany
Astellas Pharma Inc
Vical

Completed

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia

United States
Oslo University Hospital
University of Oslo

Recruiting

AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation (ACASA-TAVI)

Aortic Stenosis

Norway
Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
Xiangya Hospital of Central South University

Not yet recruiting

The Purpose of This Study is to Evaluate the Safety and Efficacy of Human TH-SC01 Cell Injection in the Treatment of Complex Perianal Fistula

Complex Perianal Fistulas

China
Sterna Biologicals GmbH & Co. KG

Completed

Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema

Mild to Moderate Atopic Dermatitis

Germany
LegoChem Biosciences, Inc

Completed

A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study

Healthy

Korea, Republic of
LigaChem Biosciences, Inc.

Active, not recruiting

Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex

Mycobacterium Abscessus Infection | Nontuberculous Mycobacterium Infection

Korea, Republic of
Hospital Juarez de Mexico

Unknown

Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

Mexico
LegoChem Biosciences, Inc
Radboud University Medical Center; University of California, San Francisco; Ludwig-Maximilians...

Completed

PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) (DECODE)

Pulmonary Tuberculosis | Infections and Infestations

Tanzania, South Africa

3

Subscribe